Top Tweets for #CancerLetters
🎉Congratulations to @BreakthroCancer PhD student @maitiuomurchu on his publication in Cancer Letters!
This study shows how adding oxygen-rich oil droplets can boost radiation’s effect on #OesophagealCancer
Read more 👉https://t.co/GZAu1iBcI8
#CancerLetters #MakeMoreSurvivors
🙌Hey @utswcancer @UTSWCancerBio @UTSWHemeOnc @UTSWScience, don't miss next week's Hamon Center seminar by Dr. Rosario Chica Parrado @Rosmery50606488! Rosario will be presenting her recently published paper (see🧵⬇️)
#ProudMentor #TripleNegativeBreastCancer #CancerLetters
🙌Nov 1 issue of #CancerLetters @sciencedirect: Dr. Rosario Chica Parrado @Rosmery50606488 finds that the combination of a #CDK4/6 inhibitor and #AKT inhibitor is highly effective in the #LuminalAndrogenReceptor (LAR) subtype of #TNBC @CarlosArteagaMD ⬇️
https://t.co/2HPirauOU6
Dual loss of #SMARCA2 #SMARCA4 is rare. PhD candidate @field_natisha in our gp leads an insightful review in #CancerLetters on disparate malignancies with this loss that impacts on #ChromatinRemodeling. #SWISNF #OvarianCancer #LungCancer. Read here:
10.1016/j.canlet.2024.217282
Super excited to share our review article just out today in #CancerLetters.
With @BaptisteMouyss1 @Marion_Le_Grand & @CamoinLuc we summarise the approaches that enable exploring the #Polypharmacology of existing drugs, to guide their optimal use.
https://t.co/A0PnrdOEjG
very happy that our study analyzing the 'growing teratoma syndrome' (GTS) has been published online (pre-proof) in #CancerLetters...
@ElsevierConnect
@UniklinikDUS
@HHU_de
@DGUrologie
@MaGIC_GCT
@teambuergeruni
#urology
#oncology
#testiscancer
https://t.co/TYGE4KIJ4l
Our study highlights the potential of mifepristone, identified through an FDA-approved drug screening for the ISR activators, as a chemosensitizer to enhance the efficacy of cisplatin-based therapy for NSCLC.
Published in #CancerLetters @OncologyAdvance https://t.co/lT5w54vvon
We are thrilled to announce our research article is published in #CancerLetters.
#CancerResearch #molecularBiology #Glioblastoma
#Cancer
https://t.co/5ObdTbJhFX
Modeling PTEN and P53 inactivation in muscle-invasive #BladderCancer. #ExpertCommentary @FaltasLab @WCMEnglanderIPM discusses work by He et al. in #CancerLetters. #ReadNow on UroToday > https://t.co/CmeGEmIke7
Proud to share our latest work regarding #SPOP mutants in #prostatecancer and #therapy implications! Thanks to @JTheurillat, @snsf_ch, and #cancerletters
Not the new #HallmarksOfCancer, but still worth reading 😉
https://t.co/un6MyKpTZY
Part of his results has been published in #CancerLetters
Splicing factor SF3B1 is overexpressed and implicated in the aggressiv... https://t.co/AGwOjUATVx
In our latest review published in #CancerLetters we show how the developmental origin of #cancers defines basic principles of #cisplatin #resistance...
@UniklinikDUS
@HHU_de
https://t.co/UIIX1ieexm
Great paper highlighting rationale for targeting #RLIP in #melanoma from @DrRaviSalgia's group in #CancerLetters (@oncologyadvance). @cityofhope science always at the cutting edge - I am trying to keep pace in the clinics! @cityofhopeoc @JackWestMD @stacywgray @minasedrakmd
Very excited to share my latest work in #Cancerletters. COX-2 promotes mammary adipose tissue inflammation, local estrogen bio... https://t.co/XKrAmDthio
Splicing factor SF3B1 is overexpressed and implicated in the aggressiveness and survival of hepatocellular carcinoma #cancerletters @ELS_Oncology https://t.co/xESjWKSKsE
Curious to know how a benign tumour can gain malignant features? It’s (almost) all about the genetics! Have a look at our recent review about #GiantCellTumour of bone now online in #CancerLetters 🤩
Our latest review about clinical and molecular features of #GiantCellTumor of #bone is finally out in #CancerLetters. Check it out at https://t.co/vmLoHh816y @OncologyAdvance
Our latest review about clinical and molecular features of #GiantCellTumor of #bone is finally out in #CancerLetters. Check it out at https://t.co/vmLoHh816y @OncologyAdvance
Excited to share our recent work showing role of a GPCR in promoting drug resistance and resistance-derived stemness in colon cancer. This will possibly help us overcome resistance in CRC.
#Cancerletters
@lunduniversity @Lundsuni
@ZebrafishRock
https://t.co/0EcGxrx1Ol
A new study has identified and characterised the contribution of a protein complex—Laminin521—to tumour progression and metastasis in #colorectalcancer, published in @OncologyAdvance #CancerLetters. @C_Shembrey @fredhollande @JaiSmithPhD
https://t.co/GgQNQhKpvn
"Writers, readers, and erasers of RNA modifications in cancer", #Review by @ManelEsteller, R. Esteve and A. Bueno in #CancerLetters @sciencedirect
📷Linking #omic approaches to #Cancer: seeking a comprehensive picture of tumor biology.
Full article 👉https://t.co/427bUhOLpd
https://t.co/82i9GNmzWj
We are thrilled to see our work dealing with multi-omics analysis of colorectal cancer-derived exosomes, obtained from clinical samples and cell lines, in order to assess the molecular basis of CRC by proposing joint pathways published in #CancerLetters
Last Seen Hashtags on Sotwe
Most Popular Users
Elon Musk 
@elonmusk
241.2M followers
Barack Obama
@barackobama
119.1M followers
Cristiano Ronaldo
@cristiano
112.9M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.3M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.5M followers
KATY PERRY
@katyperry
89M followers
Taylor Swift
@taylorswift13
83M followers
Lady Gaga
@ladygaga
74.4M followers
Virat Kohli
@imvkohli
72M followers
Kim Kardashian
@kimkardashian
70.5M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
64.9M followers
Bill Gates
@billgates
64.6M followers
The Ellen Show
@theellenshow
62.4M followers
Selena Gomez
@selenagomez
62.1M followers
CNN
@cnn
61.8M followers
X
@x
60.8M followers